Advertisement

Topics

Selective Genetics Company Profile

14:41 EST 21st November 2017 | BioPortfolio

Site specific gene therapy for soft and hard tissue repair and regeneration.

Location

11035 Roselle Street
San Diego
CA
91212
United States of America

Contact

Phone: 858 625 01000
Fax: 858 625 0050


News Articles [587 Associated News Articles listed on BioPortfolio]

Atlas Genetics announces leadership changes

Jeffrey Luber, former president and CEO at Good Start Genetics, was tapped to serve as CEO of Atlas Genetics, replacing John  -More- 

Nazneen Rahman: In tune with genetics

bmj;359/oct18_4/j4732/FAF1faDuncan SmithBiographyNazneen Rahman is professor of human genetics at the Institute of Cancer Research in London and head of the Cancer Genetics Unit at the Royal Marsden.....

A New Edition of Genetics in Medicine Is Now Available

Genetics in Medicine (vol. 19, no. 5, 2017) is available online by subscription only. Articles include: “Diagnostic Cytogenetic Testing Following Positive Noninvasive Prenatal Screening Results...

H. Lundbeck A/S: Lundbeck collaborates on large first-of-its kind study of links between genetics and psychiatric disorders

25,000 patients will be enrolled in the first study ever to combine data from genetics, cognitive tests and online surveys to explore how genetics is related to Major Depressive Disorder, Bipolar D...

Site-selective oxidation, amination and epimerization reactions of complex polyols enabled by transfer hydrogenation

Polyoxygenated aliphatic chains with multiple hydroxyl groups are common in a wide array of compounds, often with potent biological activity. Now, a new ruthenium catalyst enables selective dehydrogen...

Cancer Genetics acquires vivoPharm

Cancer Genetics and vivoPharm have entered into a definitive agreement for Cancer Genetics to acquire vivoPharm for approximately $12 million. This transaction will significantly strengthen CGI’s ...

Clues to How You Hear in a Crowd

TUESDAY, Oct. 17, 2017 -- Voice pitch plays a role in your ability to hear someone in a crowded setting, British researchers say. This process is called selective attention. It was known that selectiv...

$0.21 Earnings Per Share Expected for Myriad Genetics, Inc. (MYGN) This Quarter

Wall Street brokerages forecast that Myriad Genetics, Inc. will post earnings of $0.21 per share for the current quarter, Zacks reports. Five analysts have made estimates for Myriad Genetics' earn...

Drugs and Medications [5 Associated Drugs and Medications listed on BioPortfolio]

Patanol [Physicians Total Care, Inc.]

Emadine [Alcon Laboratories, Inc.]

Emadine®(emedastine difumarate ophthalmic solution) 0.05%

Patanol [Alcon Laboratories, Inc.]

Patanol (olopatadine hydrochloride ophthalmic solution) 0.1%

Anzemet [sanofi-aventis U.S. LLC]

ANZEMET Injection (dolasetron mesylate)

Citalopram [Rebel Distributors Corp.]

Citalopram Tablets, USP

PubMed Articles [1248 Associated PubMed Articles listed on BioPortfolio]

Modes of rapid polygenic adaptation.

Many experimental and field studies have shown that adaptation can occur very rapidly. Two qualitatively different modes of fast adaptation have been proposed: selective sweeps wherein large shifts in...

The Clinic Is My Laboratory: Life as a Clinical Geneticist.

Clinical genetics is the application of advances in genetics and medicine to real human families. It involves diagnosis, care, and counseling concerning options available to affected individuals and t...

Introduction to behavioral phenotypes in medical genetics.

Evidence of selective reporting bias in hematology journals: A systematic review.

Selective reporting bias occurs when chance or selective outcome reporting rather than the intervention contributes to group differences. The prevailing concern about selective reporting bias is the p...

25 more years.

This month, to celebrate a quarter century of excellence in genetics, we are highlighting selections from the past work we have published. We will then publish a number of forward-looking Perspectives...

Clinical Trials [904 Associated Clinical Trials listed on BioPortfolio]

Genetics Education: Preparing Physicians for the Future

This study examines the best way to teach genetics to family medicine residents. First year family medicine residents at the University of Toronto will be taught basic clinical genetics as...

Experiences of Genetics Patients With Visible Abnormalities Who Facilitate Teaching in Genetics Clinics

This study will describe the experience of patients with visible physical abnormalities in the genetics clinic when they are involved in teaching others about their condition. Information ...

Virtual Reality Intervention in Cancer Genetics

The goal of this study is to evaluate a virtual reality-based intervention for training health care providers who are not genetics specialists to effectively communicate with and counsel p...

Genetics of Asthma and Bronchial Hyperresponsiveness

To investigate the genetics of asthma by reexamining a carefully characterized population of patients with asthma, and by studying their families.

What Treatment Works for Children With Selective Mutism?

The purpose of this pilot study is to explore the outcome of a manual based treatment for children with Selective Mutism

Companies [193 Associated Companies listed on BioPortfolio]

AccessDNA, Inc.

AccessDNA is the leading online consumer resource for genetics. The company combines high-quality content about genetics with access to, and evaluation of, relevant testing, couns...

Ambry Genetics Corporation

Ambry Genetics is a privately held healthcare company with the industry’s most comprehensive suite of genetic testing solutions, benefiting 90% of all U.S. patients covered b...

Selective Insurance Group, Inc.

Selective Insurance Group, Inc. is a holding company for seven property and casualty insurance companies rated "A+" (Superior) by A.M. Best. Through independent agents, the insurance companies offer p...

Interleukin Genetics, Inc.

Interleukin Genetics, Inc. (OTCQB: ILIU) develops and markets a line of genetic tests under the Inherent Health® brand. The products empower individuals to prevent ce...

Acerta Pharma B.V.

Acerta is a leader in the field of covalent binding technology and is applying this technology to create novel selective therapies intended for the treatment of cancer and autoimm...

More Information about "Selective Genetics" on BioPortfolio

We have published hundreds of Selective Genetics news stories on BioPortfolio along with dozens of Selective Genetics Clinical Trials and PubMed Articles about Selective Genetics for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Selective Genetics Companies in our database. You can also find out about relevant Selective Genetics Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Gene Therapy
Gene therapy is the use of DNA as a pharmaceutical agent to treat disease. It derives its name from the idea that DNA can be used to supplement or alter genes within an individual's cells as a therapy to treat disease. The most common form of gene th...


Corporate Database Quicklinks



Searches Linking to this Company Record